Eris acquires Indian branded formulations business of Bangalore based Strides

Eris acquires Indian branded formulations business of Bangalore based Strides

Eris Lifesciences Ltd (Eris) acquired the Indian branded formulations business of Strides Shasun Ltd (Strides) for an aggregate cash consideration of INR 500 crores.

With this acquisition, Eris acquired the marketing and distribution rights for India for 130+ brands in the Neurology, Psychiatry, Nutraceuticals and Women Healthcare therapy areas.

The Indian branded formulations business being divested by Strides had sales of INR 181 crores for FY 2017.

Copyright © 2021 Eris Lifesciences Limited. All Rights Reserved.